Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features

Daniele Avenoso, MD, Margherita Squillario, Annalisa Barla, Alessandro Verri, Enrico Carminati, Clara Nurra, Elisabetta Todisco, MD PhD, Federica Gigli, MD, Giuliana Gregato, Claudia Poletti, Francesco Bertolini, MD PhD, Ghulam J. Mufti, MBBS, FRCP, FRCPath, DM, Mili Shah, FRCPath, Maurizio Miglino

Blood (2019) 134 (Supplement_1): 5414.

https://doi.org/10.1182/blood-2019-130153

Published: 2019

Journal Articles

Differential Alemtuzumab Dosage Effects in T-Cell Deplete Allogeneic Haematopoietic Stem Cell Transplants for Myeloid Malignancies- King's College Hospital London Experience

Varun Mehra, MBBS,MRCP,FRCPath, Daniele Avenoso, MD, Ximena Cabrera Castellano, Adrian Choy, Stefani Widya, Mili Shah, FRCPath, Shafqat Inam, MD, Shreyans Gandhi, MBBS,MDDNB,MRCP,FRCPath,MPhil, Austin Kulasekararaj, MD MRCP, FRCPath, Francesco Dazzi, PhD, Ghulam J. Mufti, MBBS, FRCP, FRCPath, DM, Antonio Pagliuca, MBBS, MA, FRCP, FRCPath, Hugues De Lavallade, Victoria Potter, MBBS, BSc, FRACP, FRCPA

Blood (2019) 134 (Supplement_1): 4622.

https://doi.org/10.1182/blood-2019-131239

Published: 2019

Journal Articles

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Livia Giannoni, MD, Fabio Guolo, MD, Paola Minetto, MD, Federica Galaverna, MD, Chiara Ghiggi, MD, Marino Clavio, MD, Samuele Bagnasco, MD, Carmen Di Grazia, MD, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Daniele Avenoso, MD, Giordana Pastori, MD, Filippo Ballerini, MD, Annalisa Kunkl, PhD, Maurizio Miglino, PhD, Roberto Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2014) 124 (21): 1027.

https://doi.org/10.1182/blood.V124.21.1027.1027

Published: 2014

Journal Articles

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Paola Minetto, MD, Fabio Guolo, MD, Marino Clavio, MD, Laura Mitscheunig, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Enrico De Astis, MD, Daniele Avenoso, MD, Livia Giannoni, MD, Giordana Pastori, MD, Lisette Del Corso, MD, Enrico Balleari, MD, Filippo Ballerini, MD, Roberto Lemoli, MD, Marco Gobbi, MD, Maurizio Miglino, PhD

Blood (2014) 124 (21): 5603.

https://doi.org/10.1182/blood.V124.21.5603.5603

Published: 2014

Journal Articles

Combined overexpression of WT1 and BAALC genes May Predict AML evolution in MDS Patients

Daniele Avenoso, MD, Enrico De Astis, MD, Nicoletta Colombo, Raffaella Grasso, PhD, Micaela Bergamaschi, MD, Paola Minetto, MD, Sara Aquino, PHD, Davide Lovera, MD, Fabio Cruciani, MD, Fabio Guolo, MD, Filippo Ballerini, PHD, Marino Clavio, MD, Letizia Canepa, MD, Ivana Pierri, MD, Carlo Marani, MD, Marco Gobbi, MD, Maurizio Miglino, PHD

Blood (2013) 122 (21): 5204.

https://doi.org/10.1182/blood.V122.21.5204.5204

Published: 2013

NARROW

Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features

Differential Alemtuzumab Dosage Effects in T-Cell Deplete Allogeneic Haematopoietic Stem Cell Transplants for Myeloid Malignancies- King's College Hospital London Experience

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Combined overexpression of WT1 and BAALC genes May Predict AML evolution in MDS Patients

Email alerts

ASH Publications

American Society of Hematology

Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features

Differential Alemtuzumab Dosage Effects in T-Cell Deplete Allogeneic Haematopoietic Stem Cell Transplants for Myeloid Malignancies- King's College Hospital London Experience

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Combined overexpression of WT1 and BAALC genes May Predict AML evolution in MDS Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only